Sunday, April 12, 2026 | 02:57 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 704 - Coronavirus Vaccine

Consistent fall in active caseload due to dip in daily cases: Health min

The decline in India's daily Covid-19 cases has ensured a consistent fall in the active caseload, which constitutes 2.36 per cent of the total infections, health ministry has said

Consistent fall in active caseload due to dip in daily cases: Health min
Updated On : 04 Jan 2021 | 1:03 PM IST

India records 16,504 new Covid-19 cases, positivity rate dips to 5.89%

Daily new Covid-19 cases in the country remained below 20,000 for the third consecutive day, while higher testing has led to further decline in the cumulative positivity rate to 5.89 per cent

India records 16,504 new Covid-19 cases, positivity rate dips to 5.89%
Updated On : 04 Jan 2021 | 12:50 PM IST

India on threshold of starting world's largest vaccination programme: PM

Prime Minister Narendra Modi on Monday said India is soon going to start the largest vaccination programme in the world

India on threshold of starting world's largest vaccination programme: PM
Updated On : 04 Jan 2021 | 12:12 PM IST

West refused to unfreeze Venezuelan funds for vaccine purchase: President

EU nations and the United States have refused Venezuela's request to unfreeze its assets, so that the sanctions-hit country could purchase a coronavirus vaccine, President Nicolas Maduro has said

West refused to unfreeze Venezuelan funds for vaccine purchase: President
Updated On : 04 Jan 2021 | 10:22 AM IST

Global Covid-19 cases surpass 85 million mark: Johns Hopkins University

The overall number of global coronavirus cases has surpassed the 85 million mark, while the deaths have surged to more than 1.84 million, according to the Johns Hopkins University

Global Covid-19 cases surpass 85 million mark: Johns Hopkins University
Updated On : 04 Jan 2021 | 8:49 AM IST

UK registers nearly 55,000 coronavirus cases in past 24 hours: Govt data

The United Kingdom registered 54,990 COVID-19 cases within the past 24 hours, a drop from 57,725 the day before, according to government figures

UK registers nearly 55,000 coronavirus cases in past 24 hours: Govt data
Updated On : 04 Jan 2021 | 7:31 AM IST

US President Trump says US coronavirus cases, deaths 'exaggerated'

Trump on Sunday said that the record-breaking numbers of new Covid-19 cases, nearly 300,000 in the past 24 hours, are exaggerated due to the Centers for Disease Control (CDC) method of counting

US President Trump says US coronavirus cases, deaths 'exaggerated'
Updated On : 04 Jan 2021 | 7:01 AM IST

STATSGURU: Here's how the world's coronavirus vaccine map looks like

Most vaccines are not yet available in plenty, and are costly, too

STATSGURU: Here's how the world's coronavirus vaccine map looks like
Updated On : 04 Jan 2021 | 6:42 AM IST

Best of BS Opinion: Next step on vaccines, farmers' protest, and more

Here's a selection of Business Standard opinion pieces for the day.

Best of BS Opinion: Next step on vaccines, farmers' protest, and more
Updated On : 04 Jan 2021 | 6:10 AM IST

India gets Covid-19 vaccine: DCGI nod for Serum Institute, Bharat Biotech

Health Minister Harsh Vardhan termed it a 'watershed moment in India's battle against Covid-19'

India gets Covid-19 vaccine: DCGI nod for Serum Institute, Bharat Biotech
Updated On : 04 Jan 2021 | 3:47 AM IST

Curbs in UK might get tougher after record increase in coronavirus cases

US distributes over 13 million doses of vaccines; 4.2 million administered

Curbs in UK might get tougher after record increase in coronavirus cases
Updated On : 04 Jan 2021 | 2:15 AM IST

Bharat Biotech: A journey that started with a scientist's return to India

First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India

Bharat Biotech: A journey that started with a scientist's return to India
Updated On : 04 Jan 2021 | 6:10 AM IST

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO

MRP for private market Rs 1,000/ dose; current licence does not allow export or sale in private market

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO
Updated On : 04 Jan 2021 | 1:02 AM IST

Serum, Bharat Biotech vaccines get restricted use approval from DCGI

While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

Serum, Bharat Biotech vaccines get restricted use approval from DCGI
Updated On : 04 Jan 2021 | 12:43 AM IST

A jab at risk: Serum's quest to lead the world in Covid-19 vaccine race

It took a chance by ramping up capacity on vaccines when they were yet to be approved and is set to emerge a global winner

A jab at risk: Serum's quest to lead the world in Covid-19 vaccine race
Updated On : 04 Jan 2021 | 6:10 AM IST

Controversy around Bharat Biotech's Covaxin approval without efficacy data

Bharat Biotech's Covaxin is based on a whole inactivated virus platform, an old technology which is used to make vaccines given to infants

Controversy around Bharat Biotech's Covaxin approval without efficacy data
Updated On : 04 Jan 2021 | 6:10 AM IST

Stock market: When even hindsight isn't 2020

Forecasting is a hit or miss business even in normal times. And at a time when even hindsight is not 2020, predict at your own peril what will happen in 2021

Image
Updated On : 03 Jan 2021 | 11:10 PM IST

Next step on vaccines

Nationwide roll-out needs meticulous planning

Next step on vaccines
Updated On : 03 Jan 2021 | 10:42 PM IST

Pharma exports likely to get a boost on coronavirus vaccine shots

However, he said that many countries, especially the European Union, are likely to step up production and increase their portfolios in an attempt to reduce import reliability.

Pharma exports likely to get a boost on coronavirus vaccine shots
Updated On : 04 Jan 2021 | 6:10 AM IST

Zydus gets DCGI nod for conducting phase-3 clinical trials of ZyCoV-D

Company to initiate trials with around 30,000 volunteers

Zydus gets DCGI nod for conducting phase-3 clinical trials of ZyCoV-D
Updated On : 03 Jan 2021 | 10:20 PM IST